Global Rotavirus Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Rotavirus Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Rotavirus Vaccines industry chain, the market status of Adult (Rotarix, RotaTeq), Pediatric (Rotarix, RotaTeq), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rotavirus Vaccines.
Regionally, the report analyzes the Rotavirus Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rotavirus Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rotavirus Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rotavirus Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Rotarix, RotaTeq).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rotavirus Vaccines market.
Regional Analysis: The report involves examining the Rotavirus Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rotavirus Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rotavirus Vaccines:
Company Analysis: Report covers individual Rotavirus Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rotavirus Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adult, Pediatric).
Technology Analysis: Report covers specific technologies relevant to Rotavirus Vaccines. It assesses the current state, advancements, and potential future developments in Rotavirus Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rotavirus Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rotavirus Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Rotavirus Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccines, with price, sales, revenue and global market share of Rotavirus Vaccines from 2019 to 2024.
Chapter 3, the Rotavirus Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rotavirus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rotavirus Vaccines.
Chapter 14 and 15, to describe Rotavirus Vaccines sales channel, distributors, customers, research findings and conclusion.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Rotavirus Vaccines industry chain, the market status of Adult (Rotarix, RotaTeq), Pediatric (Rotarix, RotaTeq), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rotavirus Vaccines.
Regionally, the report analyzes the Rotavirus Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rotavirus Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rotavirus Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rotavirus Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Rotarix, RotaTeq).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rotavirus Vaccines market.
Regional Analysis: The report involves examining the Rotavirus Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rotavirus Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rotavirus Vaccines:
Company Analysis: Report covers individual Rotavirus Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rotavirus Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adult, Pediatric).
Technology Analysis: Report covers specific technologies relevant to Rotavirus Vaccines. It assesses the current state, advancements, and potential future developments in Rotavirus Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rotavirus Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rotavirus Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- Others
- Adult
- Pediatric
- Bharat Biotech
- Merck & Co., Inc
- GlaxoSmithKline plc
- Lanzhou Institute of Biological
- Bharat Biotech International Limited
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rotavirus Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccines, with price, sales, revenue and global market share of Rotavirus Vaccines from 2019 to 2024.
Chapter 3, the Rotavirus Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rotavirus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rotavirus Vaccines.
Chapter 14 and 15, to describe Rotavirus Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rotavirus Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rotavirus Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Rotarix
1.3.3 RotaTeq
1.3.4 Rotavac
1.3.5 Rotavin-M1
1.3.6 Lanzhou lamb
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rotavirus Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Adult
1.4.3 Pediatric
1.5 Global Rotavirus Vaccines Market Size & Forecast
1.5.1 Global Rotavirus Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rotavirus Vaccines Sales Quantity (2019-2030)
1.5.3 Global Rotavirus Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Rotavirus Vaccines Product and Services
2.1.4 Bharat Biotech Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Rotavirus Vaccines Product and Services
2.2.4 Merck & Co., Inc Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck & Co., Inc Recent Developments/Updates
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business
2.3.3 GlaxoSmithKline plc Rotavirus Vaccines Product and Services
2.3.4 GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline plc Recent Developments/Updates
2.4 Lanzhou Institute of Biological
2.4.1 Lanzhou Institute of Biological Details
2.4.2 Lanzhou Institute of Biological Major Business
2.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
2.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Lanzhou Institute of Biological Recent Developments/Updates
2.5 Bharat Biotech International Limited
2.5.1 Bharat Biotech International Limited Details
2.5.2 Bharat Biotech International Limited Major Business
2.5.3 Bharat Biotech International Limited Rotavirus Vaccines Product and Services
2.5.4 Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bharat Biotech International Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROTAVIRUS VACCINES BY MANUFACTURER
3.1 Global Rotavirus Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rotavirus Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Rotavirus Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rotavirus Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rotavirus Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Rotavirus Vaccines Manufacturer Market Share in 2023
3.5 Rotavirus Vaccines Market: Overall Company Footprint Analysis
3.5.1 Rotavirus Vaccines Market: Region Footprint
3.5.2 Rotavirus Vaccines Market: Company Product Type Footprint
3.5.3 Rotavirus Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rotavirus Vaccines Market Size by Region
4.1.1 Global Rotavirus Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Rotavirus Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Rotavirus Vaccines Average Price by Region (2019-2030)
4.2 North America Rotavirus Vaccines Consumption Value (2019-2030)
4.3 Europe Rotavirus Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Rotavirus Vaccines Consumption Value (2019-2030)
4.5 South America Rotavirus Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Rotavirus Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rotavirus Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Rotavirus Vaccines Consumption Value by Type (2019-2030)
5.3 Global Rotavirus Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rotavirus Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Rotavirus Vaccines Consumption Value by Application (2019-2030)
6.3 Global Rotavirus Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rotavirus Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Rotavirus Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Rotavirus Vaccines Market Size by Country
7.3.1 North America Rotavirus Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Rotavirus Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rotavirus Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Rotavirus Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Rotavirus Vaccines Market Size by Country
8.3.1 Europe Rotavirus Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Rotavirus Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rotavirus Vaccines Market Size by Region
9.3.1 Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rotavirus Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Rotavirus Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Rotavirus Vaccines Market Size by Country
10.3.1 South America Rotavirus Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Rotavirus Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rotavirus Vaccines Market Size by Country
11.3.1 Middle East & Africa Rotavirus Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rotavirus Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rotavirus Vaccines Market Drivers
12.2 Rotavirus Vaccines Market Restraints
12.3 Rotavirus Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rotavirus Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rotavirus Vaccines
13.3 Rotavirus Vaccines Production Process
13.4 Rotavirus Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rotavirus Vaccines Typical Distributors
14.3 Rotavirus Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rotavirus Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rotavirus Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Rotarix
1.3.3 RotaTeq
1.3.4 Rotavac
1.3.5 Rotavin-M1
1.3.6 Lanzhou lamb
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rotavirus Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Adult
1.4.3 Pediatric
1.5 Global Rotavirus Vaccines Market Size & Forecast
1.5.1 Global Rotavirus Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rotavirus Vaccines Sales Quantity (2019-2030)
1.5.3 Global Rotavirus Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Rotavirus Vaccines Product and Services
2.1.4 Bharat Biotech Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Rotavirus Vaccines Product and Services
2.2.4 Merck & Co., Inc Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck & Co., Inc Recent Developments/Updates
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business
2.3.3 GlaxoSmithKline plc Rotavirus Vaccines Product and Services
2.3.4 GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline plc Recent Developments/Updates
2.4 Lanzhou Institute of Biological
2.4.1 Lanzhou Institute of Biological Details
2.4.2 Lanzhou Institute of Biological Major Business
2.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
2.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Lanzhou Institute of Biological Recent Developments/Updates
2.5 Bharat Biotech International Limited
2.5.1 Bharat Biotech International Limited Details
2.5.2 Bharat Biotech International Limited Major Business
2.5.3 Bharat Biotech International Limited Rotavirus Vaccines Product and Services
2.5.4 Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bharat Biotech International Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROTAVIRUS VACCINES BY MANUFACTURER
3.1 Global Rotavirus Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rotavirus Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Rotavirus Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rotavirus Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rotavirus Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Rotavirus Vaccines Manufacturer Market Share in 2023
3.5 Rotavirus Vaccines Market: Overall Company Footprint Analysis
3.5.1 Rotavirus Vaccines Market: Region Footprint
3.5.2 Rotavirus Vaccines Market: Company Product Type Footprint
3.5.3 Rotavirus Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rotavirus Vaccines Market Size by Region
4.1.1 Global Rotavirus Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Rotavirus Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Rotavirus Vaccines Average Price by Region (2019-2030)
4.2 North America Rotavirus Vaccines Consumption Value (2019-2030)
4.3 Europe Rotavirus Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Rotavirus Vaccines Consumption Value (2019-2030)
4.5 South America Rotavirus Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Rotavirus Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rotavirus Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Rotavirus Vaccines Consumption Value by Type (2019-2030)
5.3 Global Rotavirus Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rotavirus Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Rotavirus Vaccines Consumption Value by Application (2019-2030)
6.3 Global Rotavirus Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rotavirus Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Rotavirus Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Rotavirus Vaccines Market Size by Country
7.3.1 North America Rotavirus Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Rotavirus Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rotavirus Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Rotavirus Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Rotavirus Vaccines Market Size by Country
8.3.1 Europe Rotavirus Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Rotavirus Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rotavirus Vaccines Market Size by Region
9.3.1 Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rotavirus Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Rotavirus Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Rotavirus Vaccines Market Size by Country
10.3.1 South America Rotavirus Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Rotavirus Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rotavirus Vaccines Market Size by Country
11.3.1 Middle East & Africa Rotavirus Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rotavirus Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rotavirus Vaccines Market Drivers
12.2 Rotavirus Vaccines Market Restraints
12.3 Rotavirus Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rotavirus Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rotavirus Vaccines
13.3 Rotavirus Vaccines Production Process
13.4 Rotavirus Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rotavirus Vaccines Typical Distributors
14.3 Rotavirus Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rotavirus Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rotavirus Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Rotavirus Vaccines Product and Services
Table 6. Bharat Biotech Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co., Inc Major Business
Table 10. Merck & Co., Inc Rotavirus Vaccines Product and Services
Table 11. Merck & Co., Inc Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck & Co., Inc Recent Developments/Updates
Table 13. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc Major Business
Table 15. GlaxoSmithKline plc Rotavirus Vaccines Product and Services
Table 16. GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GlaxoSmithKline plc Recent Developments/Updates
Table 18. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 19. Lanzhou Institute of Biological Major Business
Table 20. Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
Table 21. Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Lanzhou Institute of Biological Recent Developments/Updates
Table 23. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Biotech International Limited Major Business
Table 25. Bharat Biotech International Limited Rotavirus Vaccines Product and Services
Table 26. Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bharat Biotech International Limited Recent Developments/Updates
Table 28. Global Rotavirus Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global Rotavirus Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Rotavirus Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 31. Market Position of Manufacturers in Rotavirus Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Rotavirus Vaccines Production Site of Key Manufacturer
Table 33. Rotavirus Vaccines Market: Company Product Type Footprint
Table 34. Rotavirus Vaccines Market: Company Product Application Footprint
Table 35. Rotavirus Vaccines New Market Entrants and Barriers to Market Entry
Table 36. Rotavirus Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 38. Global Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 39. Global Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Rotavirus Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 42. Global Rotavirus Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 43. Global Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Global Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Global Rotavirus Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Rotavirus Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Rotavirus Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 48. Global Rotavirus Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 49. Global Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 50. Global Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 51. Global Rotavirus Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Rotavirus Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Rotavirus Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 54. Global Rotavirus Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 55. North America Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 56. North America Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 57. North America Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 58. North America Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 59. North America Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 60. North America Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 61. North America Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Europe Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Europe Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 66. Europe Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 67. Europe Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 68. Europe Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 69. Europe Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 72. Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 73. Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 74. Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 75. Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 76. Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 77. Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 80. South America Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 81. South America Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 82. South America Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 83. South America Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 84. South America Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 85. South America Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 88. Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 89. Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Middle East & Africa Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 92. Middle East & Africa Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 93. Middle East & Africa Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Rotavirus Vaccines Raw Material
Table 96. Key Manufacturers of Rotavirus Vaccines Raw Materials
Table 97. Rotavirus Vaccines Typical Distributors
Table 98. Rotavirus Vaccines Typical Customers
Table 1. Global Rotavirus Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rotavirus Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Rotavirus Vaccines Product and Services
Table 6. Bharat Biotech Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co., Inc Major Business
Table 10. Merck & Co., Inc Rotavirus Vaccines Product and Services
Table 11. Merck & Co., Inc Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck & Co., Inc Recent Developments/Updates
Table 13. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc Major Business
Table 15. GlaxoSmithKline plc Rotavirus Vaccines Product and Services
Table 16. GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GlaxoSmithKline plc Recent Developments/Updates
Table 18. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 19. Lanzhou Institute of Biological Major Business
Table 20. Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
Table 21. Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Lanzhou Institute of Biological Recent Developments/Updates
Table 23. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Biotech International Limited Major Business
Table 25. Bharat Biotech International Limited Rotavirus Vaccines Product and Services
Table 26. Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bharat Biotech International Limited Recent Developments/Updates
Table 28. Global Rotavirus Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global Rotavirus Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Rotavirus Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 31. Market Position of Manufacturers in Rotavirus Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Rotavirus Vaccines Production Site of Key Manufacturer
Table 33. Rotavirus Vaccines Market: Company Product Type Footprint
Table 34. Rotavirus Vaccines Market: Company Product Application Footprint
Table 35. Rotavirus Vaccines New Market Entrants and Barriers to Market Entry
Table 36. Rotavirus Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 38. Global Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 39. Global Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Rotavirus Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 42. Global Rotavirus Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 43. Global Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Global Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Global Rotavirus Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Rotavirus Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Rotavirus Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 48. Global Rotavirus Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 49. Global Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 50. Global Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 51. Global Rotavirus Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Rotavirus Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Rotavirus Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 54. Global Rotavirus Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 55. North America Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 56. North America Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 57. North America Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 58. North America Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 59. North America Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 60. North America Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 61. North America Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Europe Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Europe Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 66. Europe Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 67. Europe Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 68. Europe Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 69. Europe Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 72. Asia-Pacific Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 73. Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 74. Asia-Pacific Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 75. Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 76. Asia-Pacific Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 77. Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 80. South America Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 81. South America Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 82. South America Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 83. South America Rotavirus Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 84. South America Rotavirus Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 85. South America Rotavirus Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Rotavirus Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 88. Middle East & Africa Rotavirus Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 89. Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Middle East & Africa Rotavirus Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Middle East & Africa Rotavirus Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 92. Middle East & Africa Rotavirus Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 93. Middle East & Africa Rotavirus Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Rotavirus Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Rotavirus Vaccines Raw Material
Table 96. Key Manufacturers of Rotavirus Vaccines Raw Materials
Table 97. Rotavirus Vaccines Typical Distributors
Table 98. Rotavirus Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Rotavirus Vaccines Picture
Figure 2. Global Rotavirus Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rotavirus Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Rotarix Examples
Figure 5. RotaTeq Examples
Figure 6. Rotavac Examples
Figure 7. Rotavin-M1 Examples
Figure 8. Lanzhou lamb Examples
Figure 9. Others Examples
Figure 10. Global Rotavirus Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Rotavirus Vaccines Consumption Value Market Share by Application in 2023
Figure 12. Adult Examples
Figure 13. Pediatric Examples
Figure 14. Global Rotavirus Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Rotavirus Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Rotavirus Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Rotavirus Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Rotavirus Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Rotavirus Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Rotavirus Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Rotavirus Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Rotavirus Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Rotavirus Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Rotavirus Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Rotavirus Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Rotavirus Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 56. China Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Rotavirus Vaccines Market Drivers
Figure 77. Rotavirus Vaccines Market Restraints
Figure 78. Rotavirus Vaccines Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2023
Figure 81. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 82. Rotavirus Vaccines Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Rotavirus Vaccines Picture
Figure 2. Global Rotavirus Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rotavirus Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Rotarix Examples
Figure 5. RotaTeq Examples
Figure 6. Rotavac Examples
Figure 7. Rotavin-M1 Examples
Figure 8. Lanzhou lamb Examples
Figure 9. Others Examples
Figure 10. Global Rotavirus Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Rotavirus Vaccines Consumption Value Market Share by Application in 2023
Figure 12. Adult Examples
Figure 13. Pediatric Examples
Figure 14. Global Rotavirus Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Rotavirus Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Rotavirus Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Rotavirus Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Rotavirus Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Rotavirus Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Rotavirus Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Rotavirus Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Rotavirus Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Rotavirus Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Rotavirus Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Rotavirus Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Rotavirus Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Rotavirus Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 56. China Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Rotavirus Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Rotavirus Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Rotavirus Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Rotavirus Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Rotavirus Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Rotavirus Vaccines Market Drivers
Figure 77. Rotavirus Vaccines Market Restraints
Figure 78. Rotavirus Vaccines Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2023
Figure 81. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 82. Rotavirus Vaccines Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
